Image pharmaphorum Editor Views & Analysis Results gap between digital leaders and laggards Karl Goossens, director of commercial analytics at Veeva Systems Europe, recently spoke with pharmaphorum, discussing how effective omnichannel execution drives revenue and productivity. Views & Analysis It’s time get real with healthcare's commitment to net zero Every fraction of a degree matters Views & Analysis Propelling clinical research into the 21st century Two and a half years ago, Covid-19 began to infect hundreds, then thousands, then millions of people, and was eventually declared a global pandemic. Patients Sponsored Measuring the intangible – what is the true value of a “pati... Load more results
Views & Analysis Results gap between digital leaders and laggards Karl Goossens, director of commercial analytics at Veeva Systems Europe, recently spoke with pharmaphorum, discussing how effective omnichannel execution drives revenue and productivity.
Views & Analysis It’s time get real with healthcare's commitment to net zero Every fraction of a degree matters
Views & Analysis Propelling clinical research into the 21st century Two and a half years ago, Covid-19 began to infect hundreds, then thousands, then millions of people, and was eventually declared a global pandemic.
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
